These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25581336)

  • 1. Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.
    Hou Y; Zhang C; Xu D; Sun H
    Clin Exp Immunol; 2015 May; 180(2):250-4. PubMed ID: 25581336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.
    Hou YF; Zhang YC; Jiao YL; Wang LC; Li JF; Pan ZL; Yang QR; Sun HS; Zhao YR
    Lupus; 2010 Jan; 19(1):20-6. PubMed ID: 19926642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
    Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
    Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis.
    Sun HS; Liu DX; Bai YY; Hu NW
    Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
    PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion.
    Wang S; Zhao YR; Jiao YL; Wang LC; Li JF; Cui B; Xu CY; Shi YH; Chen ZJ
    Biochem Biophys Res Commun; 2007 Aug; 360(3):696-701. PubMed ID: 17617375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
    Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
    Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
    Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
    Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.
    Jiao YL; Ma CY; Wang LC; Cui B; Zhang J; You L; Chen ZJ; Li JF; Zhao YR
    J Clin Immunol; 2008 Jul; 28(4):343-9. PubMed ID: 18297378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus.
    Gambino CM; Di Bona D; Aiello A; Carru C; Duro G; Guggino G; Ferrante A; Zinellu A; Caruso C; Candore G; Accardi G
    Hum Immunol; 2018 Mar; 79(3):172-177. PubMed ID: 29395276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
    Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.
    Segerberg F; Lundtoft C; Reid S; Hjorton K; Leonard D; Nordmark G; Carlsten M; Hagberg N
    Front Immunol; 2019; 10():2164. PubMed ID: 31572377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
    Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
    Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
    Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.